How Can I Manage Scanxiety During Thyroid Cancer Follow-Up?
At a Glance
Scanxiety can persist long after thyroid cancer treatment, but planning how results will be shared, using relaxation or counseling, joining moderated support, and reviewing thyroid hormone targets with your clinician can make monitoring more manageable.
Experiencing intense anxiety, stress, or dread in the days and weeks leading up to routine thyroid lab draws or ultrasounds is a very common and understandable experience for thyroid cancer survivors, but it is not something you have to endure alone. This phenomenon, often called scanxiety, can persist for years after your initial treatment. Even when you are doing well, the ongoing need for monitoring can take a significant psychological toll.
If you have postsurgical hypothyroidism following treatment for differentiated thyroid cancer (the most common type), regular follow-up is an individualized but necessary part of your care. However, these appointments often trigger a powerful fear of cancer recurrence or anxiety about receiving “bad” lab results. Research shows that this fear and anxiety are frequently reported by survivors and can persist long-term, regardless of your actual clinical risk level [1][2][3].
Understanding Your Monitoring Routine
It is helpful to separate your routine tests into two categories: hormone management and cancer surveillance. Your endocrinologist will individualize your schedule based on your cancer type, the extent of your surgery, whether you had radioactive iodine, and your ongoing risk of recurrence.
- Hormone Management (TSH): Thyroid-stimulating hormone (TSH) is measured to ensure your levothyroxine dose is correct.
- Cancer Surveillance (Thyroglobulin and Ultrasounds): Thyroglobulin is a protein produced by thyroid tissue. After a total thyroidectomy, it is used as a tumor marker, often checked alongside anti-thyroglobulin antibodies. A single detectable thyroglobulin result does not automatically mean the cancer has returned; it can come from normal residual thyroid tissue and is interpreted based on trends over time and ultrasound results [2].
The Psychological Impact of Chronic Monitoring
Lifelong surveillance is meant to be precautionary, but it can feel like a constant reminder of your diagnosis. The emotional burden is profound, and studies have shown that anxiety and distress in thyroid cancer survivors are often higher than in the general population [4][5].
This ongoing stress can manifest as:
- Fear of Cancer Recurrence (FCR): A persistent worry that the cancer will return. It is one of the most common survivorship concerns [1].
- Scanxiety: Spikes in anxiety, irritability, or difficulty sleeping specifically tied to upcoming clinic appointments, blood draws, or neck ultrasounds [6].
- Intolerance of Uncertainty: Finding it difficult to cope with the “waiting game” between having your labs drawn and getting the results [7].
It is important to know that anxiety does not always track with your objective medical risk—you can have a very low risk of recurrence and still experience high levels of anxiety [1]. Routine psychosocial distress screening is recommended in many cancer-care settings to help identify patients who need support [8].
Mental Health Crisis Guidance: If your distress becomes overwhelming and you experience thoughts of self-harm, severe panic, or an inability to function or stay safe, contact your local emergency services or a mental health crisis hotline immediately. Do not wait for a routine appointment to seek help.
The Role of Your Thyroid Medication
After thyroid cancer, some patients are placed on a specialized, risk-adapted medication plan called TSH suppression. This involves taking a carefully calculated dose of levothyroxine to keep your TSH levels lower than normal, which reduces the stimulation of any remaining thyroid cells. TSH suppression is not appropriate for everyone; the target ranges vary based on your specific recurrence risk, age, and heart and bone health [9][10].
While studies cannot prove that suppression directly causes the emotional experience of anxiety, taking excess thyroid hormone can cause thyrotoxicosis (having too much thyroid hormone). This can lead to physical symptoms that mimic or worsen anxiety, such as jitteriness, insomnia, heat intolerance, tremor, and palpitations [9]. Prolonged over-replacement can also increase risks for bone loss and heart rhythm issues.
Never alter your levothyroxine dose on your own. Always discuss your symptoms and TSH targets with your clinician [11].
Medical Red Flags: Seek urgent medical care if you experience severe chest pain, fainting, severe shortness of breath, or a sustained, markedly irregular, or rapid heartbeat.
Strategies for Coping and Support
There are several evidence-based strategies that may help you cope with scanxiety and the psychological impact of long-term monitoring:
- Seek Professional Psychological Support: A psycho-oncologist (a mental health professional specializing in cancer) or a therapist can be incredibly helpful. Approaches like Cognitive Behavioral Therapy (CBT), which helps change negative thought patterns, and Acceptance and Commitment Therapy (ACT), which focuses on accepting what is out of your control, may benefit patients dealing with fear of recurrence [12][13].
- Mind-Body Resiliency Programs: Interventions combining relaxation techniques, mindfulness meditation, and positive psychology skills may help reduce general anxiety in cancer survivors [14].
- Connect with Moderated Support Groups: Talking with other thyroid cancer survivors can reduce feelings of isolation. Peer support interventions have been shown to improve emotional well-being, though it is best to seek moderated groups, as reading alarming online stories can sometimes increase anxiety [15].
- Create an Appointment Action Plan: Address the uncertainty that fuels fear of recurrence by planning ahead [16]. Talk to your doctor about how you want to receive your results—do you prefer a planned phone call, a message in your patient portal, or an in-person appointment? Knowing exactly when and how you will get your results can reduce the anxiety of waiting. Arrange to bring a support person to your appointments, and plan a distracting activity for the waiting period.
- Review Your Survivorship Plan: Have an open discussion with your endocrinologist about your long-term goals. Ask if your current TSH target is still appropriate for your risk level, as safely reducing TSH suppression when it is no longer medically necessary may improve your physical symptoms and overall quality of life [11][17].
Common questions in this guide
What is scanxiety after thyroid cancer treatment?
What can I do to reduce anxiety before thyroid cancer monitoring?
Can my levothyroxine dose make anxiety symptoms worse?
Does a detectable thyroglobulin result mean my thyroid cancer has returned?
When should I seek professional help for scanxiety?
What should I do if thyroid cancer monitoring anxiety becomes overwhelming?
Related questions
Show more
Get notified when new evidence is published on postsurgical hypothyroidism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review.
Hampton J, Alam A, Zdenkowski N, et al.
Thyroid : official journal of the American Thyroid Association 2024; (34(5)):541-558 doi:10.1089/thy.2023.0642.
PMID: 38368547 - 2
Validation of the Czech version of the nine-item Fear of Cancer Recurrence Inventory in differentiated thyroid cancer survivors.
Nemcikova P, Javurkova A, Raudenska J, et al.
Endocrine 2026; (91(1)).
PMID: 41949688 - 3
Fear of cancer recurrence in papillary thyroid cancer: a comparison across ATA risk groups and influencing factors.
Altıntop SE, Barlas T, Yalcin MM, et al.
Endocrine 2026; (91(1)).
PMID: 42440008 - 4
Differentiated thyroid cancer: effect on quality of life, depression, and anxiety.
Helvacı BC, Yalçın MM, Yalcın ŞNG, et al.
Hormones (Athens, Greece) 2023; (22(3)):367-374 doi:10.1007/s42000-023-00449-3.
PMID: 37084015 - 5
Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study.
Dionisi-Vici M, Fantoni M, Botto R, et al.
Endocrine 2021; (74(3)):603-610 doi:10.1007/s12020-021-02786-y.
PMID: 34143334 - 6
The Thyroid Cancer Modified Anxiety Scale (TC-MAX): Development and External Validation of a Thyroid Cancer Distress Instrument.
Bastien AJ, Kim S, Zalt C, et al.
Thyroid : official journal of the American Thyroid Association 2026; (36(10)):1043-1052 doi:10.1177/10507256261475819.
PMID: 42578929 - 7
Scanxiety and Fear of Recurrence in Young Adult Female Breast and Gynaecological Cancer Survivors: Investigating Shared Mechanisms.
Patel DS, Webster SN, Dowling EJ, et al.
Psycho-oncology 2024; (33(12)):e70050 doi:10.1002/pon.70050.
PMID: 39694862 - 8
Anxiety, Depression, and Quality of Life Among Survivors of Differentiated Thyroid Cancer in Türkiye.
Hamurcu HD, Kokurcan A, Uçmak G, Çayköylü A
International journal of psychiatry in medicine 2026; (61(5)):558-573 doi:10.1177/00912174251413349.
PMID: 41460088 - 9
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
Deguchi-Horiuchi H, Ito M, Takahashi S, et al.
Endocrine journal 2024; (71(4)):373-381 doi:10.1507/endocrj.EJ23-0497.
PMID: 38296546 - 10
Thyroid Hormone Suppression Therapy.
Biondi B, Cooper DS
Endocrinology and metabolism clinics of North America 2019; (48(1)):227-237 doi:10.1016/j.ecl.2018.10.008.
PMID: 30717904 - 11
A Qualitative Study of Clinician Barriers and Facilitators to De-escalation of Thyroid Stimulating Hormone Suppression in Thyroid Cancer Survivors.
Francis-Levin N, Tan CY, Gay BL, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(3)):392-400 doi:10.1016/j.eprac.2025.12.009.
PMID: 41419177 - 12
Therapeutic intervention in fear of cancer recurrence in adult oncology patients: a systematic review.
Paperák P, Javůrková A, Raudenská J
Journal of cancer survivorship : research and practice 2023; (17(4)):1017-1035 doi:10.1007/s11764-022-01277-x.
PMID: 36307611 - 13
Interventions to Manage Uncertainty and Fear of Recurrence in Female Breast Cancer Survivors: A Review of the Literature.
Dawson G, Madsen LT, Dains JE
Clinical journal of oncology nursing 2016; (20(6)):E155-E161 doi:10.1188/16.CJON.E155-E161.
PMID: 27857253 - 14
Managing, not lessening, uncertainty: a novel mind-body intervention for fear of cancer recurrence.
Christie AJ, Bolden C, Park ER, et al.
Journal of cancer survivorship : research and practice 2025; doi:10.1007/s11764-025-01886-2.
PMID: 40887510 - 15
Peer support interventions of adolescent and young adult childhood cancer survivors: A mixed methods systematic review.
Park M, Kim G
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2026; (82()):103197 doi:10.1016/j.ejon.2026.103197.
PMID: 42061182 - 16
Fear of cancer recurrence among cancer survivors in South Korea: high prevalence and predictors of clinical FCR.
Yun HY, Kang N, Kim M, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2026; (34(8)).
PMID: 42509360 - 17
Tailoring TSH suppression in differentiated thyroid carcinoma: evidence, controversies, and future directions.
Song X, Zhi X, Qian L
Endocrine 2025; (89(1)):1-19 doi:10.1007/s12020-025-04223-w.
PMID: 40199841
This page is for informational purposes only and does not constitute medical or mental-health advice. Discuss your anxiety, thyroid hormone symptoms, and support options with your endocrinologist or a qualified mental-health professional.